What is Cefepime?
Cefepime is an injectable, broad-spectrum antibiotic belonging to the fourth-generation cephalosporin class of antibiotics. It works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. Cefepime has a wide range of activity against Gram-positive and Gram-negative bacteria, including strains resistant to other cephalosporins, and is effective in treating various infections such as pneumonia, urinary tract infections, skin and soft tissue infections, and meningitis.
What is Cefepime used for?
Cefepime is a fourth-generation cephalosporin antibiotic medication used to treat various bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall, ultimately leading to the death of the bacteria. Cefepime has a broad spectrum of activity and is effective against many Gram-positive and Gram-negative bacteria, including Escherichia coli (E. coli), Pseudomonas aeruginosa, and various species of Streptococcus.
Cefepime is typically administered intravenously and is available in 500 mg, 1 gram, and 2 gram vials for injection. It should be used under the guidance of a healthcare provider, as it may interact with other medications or worsen certain medical conditions. Common side effects associated with cefepime include headache, dizziness, nausea, vomiting, and infusion site reactions. However, this medication is generally well-tolerated by most patients. Cefepime is commonly used to treat infections of the skin, respiratory tract, urinary tract, and central nervous system (CNS), among other areas of the body.
As a fourth-generation cephalosporin, cefepime has several characteristics that distinguish it from older generations of antibiotics. It maintains broad-spectrum activity in the presence of beta-lactamase-producing bacteria and has been shown to have good penetration into various tissues, including the CNS.
Cefepime side effects
• Anemia • Anorexia • Decreased renal function • Diarrhea • Dyspepsia • Hypokalemia • Increased creatine kinase levels • Increased liver enzymes • Leukopenia • Nausea • Phlebitis/Thrombosis at site of injection • Pneumonia (in patients with risk factors for bronchopulmonary aspiraton syndrome) • Psychotic behavior, including delirium and hallucinations • Thirst • Urinary frequency • Vaginal candidiasis
Disclaimer
The content on this website is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The information provided here is based on general research and may not apply to individual circumstances. We do not guarantee the accuracy or completeness of any content on this website. Always consult with a healthcare professional before making any changes to your medication or health routine.